---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042933"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2026-09-16T20:38:00+00:00"
generated_at: "2026-09-16T20:39:12.212946+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Lipocine presents at H.C. Wainwright conference; no material news in filing

## Summary
- Presented at H.C. Wainwright 28th Annual Global Investor Conference on Sept 16, 2026 in New York City.
- Filing contains no financial results, guidance, or corporate developments; presentation content not available.
- No specific facts beyond the conference appearance and date are disclosed in the 8-K.
- Ticker LPCN; common stock listed on NASDAQ.

## SEC filing metadata
- accession: 0001493152-26-042933
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2026-09-16T20:38:00+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042933/0001493152-26-042933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042933/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042933
- JSON: https://secwatch.observer/filing/0001493152-26-042933.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042933.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.